• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 25-NSE filed by NorthView Acquisition Corporation

    5/22/25 3:34:04 PM ET
    $NVAC
    Medical/Dental Instruments
    Health Care
    Get the next $NVAC alert in real time by email
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    UNITED STATES
    OMB APPROVAL
    OMB Number: 3235-0080
    Expires: March 31, 2018
    Estimated average burden
    hours per response: 1.7
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 25
    NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
    UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
    Commission File Number 333-257156
    Issuer: NorthView Acquisition Corp
    Exchange: Nasdaq Stock Market LLC
    (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
    Address: 5959 Horton, #450
    Emeryville CALIFORNIA 94608
    Telephone number: 212-494-9022
    (Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
    Common Stock, Rights, Warrants
    (Description of class of securities)
    Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
    17 CFR 240.12d2-2(a)(1)
    17 CFR 240.12d2-2(a)(2)
    17 CFR 240.12d2-2(a)(3)
    17 CFR 240.12d2-2(a)(4)
    Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
    Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
    Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
    2025-05-22 By Aravind Menon Hearings Advisor
    Date Name Title
    1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $NVAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NVAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NVAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Failure to Complete Initial Business Combination

      New York, NY, Dec. 26, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") indicating that (i) the Staff has determined that the Company's securities will be delisted from The Nasdaq Stock Market; (ii) trading of the Company's Common Stock, Rights, and Warrants will be suspended at the opening of business on December 27, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the "SEC"), which will remove the Company's securities from listing on The Nasdaq Stock Market. Pursuant to

      12/26/24 4:30:00 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • NorthView Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q

      New York, NY, Dec. 11, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") stating that because the Company has not yet filed its Form 10-Q for the period ended September 30, 2024, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). This notification has no immediate effect on the listing of the Company's shares on Nasdaq. However, if the Company fails to timely regain compliance with the

      12/11/24 6:30:00 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • NorthView Acquisition Corporation Announces Exception Granted by Nasdaq to Permit to The Company to Regain Compliance with Listing Rules

      New York, NY, Sept. 13, 2024 (GLOBE NEWSWIRE) -- NorthView Acquisition Corporation. (NASDAQ:NVAC) (the "Company") announced that it has received a notice (the "Notice") from The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an exception to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the "SEC"). Pursuant to the terms of the exception, the Company must file its Quarterly Reports on Form 10-Q for the periods ending March 31, 2024 and June 30, 2024 on or prior to October 14, 2024. If the Company does not satisfy the terms of the exception, the

      9/13/24 4:30:00 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care

    $NVAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by NorthView Acquisition Corporation

      SC 13G - NorthView Acquisition Corp (0001859807) (Subject)

      3/27/24 6:05:55 AM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

      SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

      2/22/24 9:05:41 AM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by NorthView Acquisition Corporation (Amendment)

      SC 13G/A - NorthView Acquisition Corp (0001859807) (Subject)

      2/14/24 4:53:53 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care

    $NVAC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by NorthView Acquisition Corporation

      25-NSE - NorthView Acquisition Corp (0001859807) (Subject)

      5/22/25 3:34:04 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by NorthView Acquisition Corporation

      424B3 - NorthView Acquisition Corp (0001859807) (Filer)

      5/15/25 5:24:53 PM ET
      $NVAC
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by NorthView Acquisition Corporation

      EFFECT - NorthView Acquisition Corp (0001859807) (Filer)

      5/15/25 12:15:07 AM ET
      $NVAC
      Medical/Dental Instruments
      Health Care